December 2025
The predictive disease analytics market size reached USD 4.97 billion in 2025 and is expected to be worth around USD 23.08 billion by 2035 with a CAGR of 16.6%.
January 2026
The predictive analytics market size is calculated at USD 17.49 billion in 2025 and is projected to hit around USD 113.46 billion by 2035 with a CAGR of 20.56%.
January 2026
The global healthcare predictive analytics market size is projected to hit around USD 180.67 billion by 2035 from USD 22.31 billion in 2025 with a CAGR of 23.26%.
July 2026
The life science analytics market size was valued at USD 11.97 billion in 2025 and is expected to hit around USD 26.63 billion by 2035, growing at a CAGR of 8.32%.
July 2026
The global mobile apps and web analytic market size is estimated to hit around USD 65.79 billion by 2035 from USD 14.86 billion in 2025 with a CAGR of 16.04%.
July 2026
The global infectious disease vaccines market size is estimated to hit around USD 77.04 billion by 2035 increasing from USD 38.83 billion in 2025, with a CAGR of 7.09%.
July 2026
The global speech analytics market size reached USD 4.42 billion in 2024 and is projected to hit around USD 18.85 billion by 2034, with a remarkable CAGR of 15.62%.
July 2026
The global semiconductor yield analytics tools market size is estimated to hit around USD 2.18 billion by 2034 increasing from USD 0.94 billion in 2024, with a CAGR of 8.76%
July 2026
The IT operations analytics market size accounted for USD 22.47 billion in 2025 and is expected to hit around USD 278.70 billion by 2035 with a CAGR of 28.63%.
July 2026
The global sports analytics market size is valued at USD 5.47 billion in 2025 and is expected to hit around USD 29.75 billion by 2034, growing at a CAGR of 20.63%.
July 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global chronic disease management market size was estimated at USD 6.61 billion in 2025 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The global predictive biomarkers market size is valued at USD 28.88 billion in 2025 and is predicted to hit around USD 155.53 billion by 2035, at a CAGR of 18.34%.
June 2026
The clinical data analytics solutions market size is valued at USD 5.42 billion in 2025 and is projected to hit around USD 10.42 billion by 2035 with a CAGR of 6.75%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
May 2026
The global biopharma analytics market is expanding as companies adopt data-driven tools to accelerate drug discovery and clinical development.
May 2026
The infectious respiratory disease diagnostics market size is projected to hit around USD 96.57 billion by 2035 from USD 57.55 billion in 2025 with a CAGR of 5.31%.
May 2026
The global disease management apps market size is calculated at USD 10.20 billion in 2025 and is projected to hit around USD 27 billion by 2035 with a CAGR of 10.22%.
May 2026
The global procurement analytics market size was calculated at USD 6.49 billion in 2025 and is predicted to hit around USD 50.92 billion by 2035 at a CAGR of 22.88%.
May 2026
The global diabetic kidney disease market size was valued at USD 3.25 billion in 2025 and is projected to hit around USD 5.23 billion by 2035 with a CAGR of 4.87%.
May 2026
The global graves disease (overactive thyroid) market size is estimated to hit around USD 3.69 billion by 2035 increasing from USD 2.26 billion in 2025, with a CAGR of 5.02%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com